Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

GRIN3B

Introduction

Glutamate [NMDA] receptor subunit 3B is a protein that in humans is encoded by the GRIN3B gene.[1]

See also

See also

References

References

  1. ↑ “Entrez Gene: GRIN3B glutamate receptor, ionotropic, N-methyl-D-aspartate 3B”.
Further reading

Further reading

  • Schröder HC, Perovic S, Kavsan V, et al. (1998). “Mechanisms of prionSc- and HIV-1 gp120 induced neuronal cell death”. Neurotoxicology. 19 (4–5): 683–8. PMID 9745929.
  • Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995). “Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95”. Science. 269 (5231): 1737–40. doi:10.1126/science.7569905. PMID 7569905.
  • Magnuson DS, Knudsen BE, Geiger JD, et al. (1995). “Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity”. Ann. Neurol. 37 (3): 373–80. doi:10.1002/ana.410370314. PMID 7695237.
  • Lannuzel A, Lledo PM, Lamghitnia HO, et al. (1996). “HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons”. Eur. J. Neurosci. 7 (11): 2285–93. doi:10.1111/j.1460-9568.1995.tb00649.x. PMID 8563977.
  • Corasaniti MT, Melino G, Navarra M, et al. (1996). “Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase”. Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration. 4 (3): 315–21. doi:10.1016/1055-8330(95)90021-7. PMID 8581564.
  • Pittaluga A, Pattarini R, Severi P, Raiteri M (1996). “Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120”. AIDS. 10 (5): 463–8. doi:10.1097/00002030-199605000-00003. PMID 8724036.
  • Wu P, Price P, Du B, et al. (1996). “Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons”. NeuroReport. 7 (5): 1045–9. doi:10.1097/00001756-199604100-00018. PMID 8804048.
  • Bennett BA, Rusyniak DE, Hollingsworth CK (1996). “HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures”. Brain Res. 705 (1–2): 168–76. doi:10.1016/0006-8993(95)01166-8. PMID 8821747.
  • Toggas SM, Masliah E, Mucke L (1996). “Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine”. Brain Res. 706 (2): 303–7. doi:10.1016/0006-8993(95)01197-8. PMID 8822372.
  • Dreyer EB, Lipton SA (1996). “The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid”. Eur. J. Neurosci. 7 (12): 2502–7. doi:10.1111/j.1460-9568.1995.tb01048.x. PMID 8845955.
  • Bonaldo MF, Lennon G, Soares MB (1997). “Normalization and subtraction: two approaches to facilitate gene discovery”. Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID 8889548.
  • Raber J, Toggas SM, Lee S, et al. (1997). “Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase”. Virology. 226 (2): 362–73. doi:10.1006/viro.1996.0664. PMID 8955056.
  • New DR, Maggirwar SB, Epstein LG, et al. (1998). “HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism”. J. Biol. Chem. 273 (28): 17852–8. doi:10.1074/jbc.273.28.17852. PMID 9651389.
  • Wang P, Barks JD, Silverstein FS (1999). “Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats”. Neuroscience. 88 (2): 585–97. doi:10.1016/S0306-4522(98)00242-5. PMID 10197777.
  • Howard SA, Nakayama AY, Brooke SM, Sapolsky RM (1999). “Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures”. Exp. Neurol. 158 (1): 164–70. doi:10.1006/exnr.1999.7080. PMID 10448428.
  • Xin KQ, Hamajima K, Hattori S, et al. (1999). “Evidence of HIV type 1 glycoprotein 120 binding to recombinant N-methyl-D-aspartate receptor subunits expressed in a baculovirus system”. AIDS Res. Hum. Retroviruses. 15 (16): 1461–7. doi:10.1089/088922299309973. PMID 10555109.
  • Haughey NJ, Nath A, Mattson MP, et al. (2001). “HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity”. J. Neurochem. 78 (3): 457–67. doi:10.1046/j.1471-4159.2001.00396.x. PMID 11483648.
  • Bonavia R, Bajetto A, Barbero S, et al. (2001). “HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons”. Biochem. Biophys. Res. Commun. 288 (2): 301–8. doi:10.1006/bbrc.2001.5743. PMID 11606043.
  • Nishi M, Hinds H, Lu HP, et al. (2002). “Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner”. J. Neurosci. 21 (23): RC185. PMID 11717388.
External links